| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/15/1999 | WO1998045322A3 Diagnosis method and reagents |
| 04/15/1999 | DE19745151A1 New N-2-Mercapto-3-phenyl-propionyl di:peptide derivatives |
| 04/15/1999 | DE19745146A1 New N-acyl N-acyl-aminoethyl alpha-amino acid derivatives |
| 04/15/1999 | DE19744127A1 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals |
| 04/15/1999 | CA2306245A1 Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, preparation methods and uses in therapy |
| 04/15/1999 | CA2305786A1 Use of neuronal and lymphocytic potassium canal inhibitors for treating neurological diseases of immune origin |
| 04/15/1999 | CA2305751A1 Medicaments |
| 04/15/1999 | CA2305732A1 Methods for screening drugs to predict tardive dyskinesia |
| 04/15/1999 | CA2305685A1 101 human secreted proteins |
| 04/15/1999 | CA2305679A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | CA2305538A1 Novel compounds useful as neuro-protective agents |
| 04/15/1999 | CA2305535A1 Controlled release solid dosage forms of lithium carbonate |
| 04/15/1999 | CA2305348A1 Naphtho-imidazo[1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders |
| 04/15/1999 | CA2305342A1 Novel heterocyclic derivatives useful in treating central nervous system disorders |
| 04/15/1999 | CA2305190A1 Serotonin containing formulation for oral administration and method of use |
| 04/15/1999 | CA2304826A1 5ht4 agonists and antagonists |
| 04/15/1999 | CA2304630A1 Taste masked formulations |
| 04/15/1999 | CA2304152A1 Novel vitamin d analogues |
| 04/15/1999 | CA2304116A1 Peptide-containing .alpha.-ketoamide cysteine and serine protease inhibitors |
| 04/15/1999 | CA2303449A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | CA2273274A1 Dosage forms having improved release properties |
| 04/14/1999 | EP0908519A1 Novel glucosaminidase from Staphylococcus aureus |
| 04/14/1999 | EP0908459A1 5-HT4 Agonists and antagonists |
| 04/14/1999 | EP0908458A1 Substituted pyridylmethylpiperazine and -piperidine derivatives, their preparation and their use for treating central nervous system (CNS) disorders |
| 04/14/1999 | EP0908456A1 Pyrazole derivatives, their preparation and their use in drugs |
| 04/14/1999 | EP0908454A2 Oxazoles, thiazoles, oxazolines, oxadiazoles and benzoxazoles useful as neuro-protective agents |
| 04/14/1999 | EP0908186A2 Method for treating pain |
| 04/14/1999 | EP0907738A1 Novel compounds |
| 04/14/1999 | EP0907732A2 Polynucleotides encoding secreted proteins |
| 04/14/1999 | EP0907729A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS |
| 04/14/1999 | EP0907658A1 Neuropeptide y agonists |
| 04/14/1999 | EP0907635A1 Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| 04/14/1999 | EP0907369A1 Materials and methods for treatment of plaquing diseases |
| 04/14/1999 | EP0907364A1 Pharmaceutical compositions |
| 04/14/1999 | EP0907318A1 Antioxidant compound |
| 04/14/1999 | EP0810991B1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists |
| 04/14/1999 | EP0759934B1 Neurotensin antagonist peptides |
| 04/14/1999 | EP0652879B1 1-azaadamantane derivatives as 5-ht4 agonists or antagonists and/or 5-ht3 antagonists |
| 04/14/1999 | EP0605501B1 Method and compositions for the treatment of cerebral palsy |
| 04/14/1999 | EP0584285B1 Treatment of schizophrenia by cholinesterase inhibitors |
| 04/14/1999 | EP0510068B1 NEW CENTRALLY ACTING 6,7,8,9-TETRAHYDRO-3H-BENZ(e)INDOLE HETEROCYCLICS |
| 04/14/1999 | CN1214048A Benzopyran derivatives having leukotriene-antagonistic action |
| 04/14/1999 | CN1214047A Novel aromatic piperazines derived from substituted cycloazanes, method for prepairing same, pharmaceutical compsns, and use thereof as drugs |
| 04/14/1999 | CN1214046A 4,5-dihydronaphth [1,2-C] isoxazoles and derivatives thereof having CNS activity |
| 04/14/1999 | CN1214043A Benzyl(idene)-lactam derivatives, their prepn. and their use as selective (ant) agaonists of 5-ht1A-and/or 5-ht1D receptors |
| 04/14/1999 | CN1213970A Method for treating autism |
| 04/14/1999 | CN1213968A Use of (+)-'alpha'-(2,3-dimethyoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders |
| 04/14/1999 | CN1213966A Method for treating bipolar disorder |
| 04/14/1999 | CN1213560A Medicine for treating diseases of central nervous system and its prodn. method |
| 04/13/1999 | CA2057034C Onset hastened/enhanced antipyretic response |
| 04/13/1999 | CA2005547C Derivatives of 1,7' (imidazo-(1,2-a)-pyridine)5'-(6'h)ones |
| 04/09/1999 | CA2246635A1 Novel glucosaminidase |
| 04/08/1999 | WO1999016874A1 Nucleic acids coding for proteins capable of interacting with presenilins |
| 04/08/1999 | WO1999016786A1 The use of steroid saponin compounds to prevent senility, and novel steroid saponin compounds |
| 04/08/1999 | WO1999016771A1 Condensed benzothiopyranic compounds |
| 04/08/1999 | WO1999016753A2 Tricyclic 3-oxo-propanenitrile compounds |
| 04/08/1999 | WO1999016746A1 Aminoalkylphenol derivatives and related compounds |
| 04/08/1999 | WO1999016745A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | WO1999016741A2 Lipophilic diesters of chelating agents |
| 04/08/1999 | WO1999016464A1 Modulation of nitric oxide production |
| 04/08/1999 | WO1999016461A1 Antistress agents and functional foods |
| 04/08/1999 | WO1999016460A2 Apolipoprotein e/growth factor complexes and methods of use |
| 04/08/1999 | WO1999016452A1 THERAPEUTICALLY EFFECTIVE 1α, 25-DIHYDROXYVITAMIN D3 ANALOGS |
| 04/08/1999 | WO1999016442A2 Sustained release tablet formulation to treat parkinson disease |
| 04/08/1999 | WO1999016439A1 CHRONIC, BOLUS ADMINISTRATION OF D-threo METHYLPHENIDATE |
| 04/08/1999 | WO1999016313A1 2-methyl-thieno-benzodiazepine formulation |
| 04/08/1999 | WO1999004771A3 Use of levobupivacaine |
| 04/08/1999 | WO1998055638A9 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof |
| 04/08/1999 | CA2305781A1 Nucleic acids coding for proteins capable of interacting with presenilins |
| 04/08/1999 | CA2305140A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | CA2304720A1 Apolipoprotein e/growth factor complexes and methods of use |
| 04/08/1999 | CA2304719A1 Modulation of nitric oxide production |
| 04/08/1999 | CA2304056A1 Therapeutically effective 1.alpha., 25-dihydroxyvitamin d3 analogs |
| 04/08/1999 | CA2302027A1 Condensed benzothiopyranic compounds |
| 04/08/1999 | CA2302025A1 Tricyclic 3-oxo-propanenitrile compounds |
| 04/08/1999 | CA2301869A1 Sustained release tablet formulation to treat parkinson disease |
| 04/08/1999 | CA2245937A1 Novel histidine kinase |
| 04/08/1999 | CA2245924A1 A method of identifying agonists and antagonists for tumor necrosis related receptors tr1, tr3 and tr5 |
| 04/07/1999 | EP0906955A2 FtsY |
| 04/07/1999 | EP0906912A1 Indanol derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/07/1999 | EP0906761A2 Method of preparing and using phytochemicals |
| 04/07/1999 | EP0906755A2 Use of phenyl oxazole or phenyl thiazole derivatives for treating neuropathic pain |
| 04/07/1999 | EP0906752A1 Use of a plant extract of the Rosaceae family |
| 04/07/1999 | EP0906421A1 Enhanced efficacy of liposomal antisense delivery |
| 04/07/1999 | EP0906315A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 04/07/1999 | EP0906310A1 OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 04/07/1999 | EP0906309A1 Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride |
| 04/07/1999 | EP0906308A1 Azetidine, pyrrolidine and piperidine derivatives as 5-ht1d receptor agonists |
| 04/07/1999 | EP0906303A1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 04/07/1999 | EP0906301A1 Benzofuryl derivatives and their use |
| 04/07/1999 | EP0906294A1 Benzoxazinone dopamine d4 receptor antagonists |
| 04/07/1999 | EP0906284A1 Tricyclic amine derivatives |
| 04/07/1999 | EP0906276A1 Novel vitamin d analogues |
| 04/07/1999 | EP0906121A1 Vasoactive effects and free radical generation by beta-amyloid peptides |
| 04/07/1999 | EP0906102A1 A process for regulating vagal tone |
| 04/07/1999 | EP0906090A1 Method for preventing and treating peripheral neurophathy by administering selegiline |
| 04/07/1999 | EP0906089A2 Buccal delivery system |
| 04/07/1999 | EP0906088A1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 04/07/1999 | EP0857065B1 Use of 2-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for prophylaxis and treatment of sequelae of acute and chronic reduced circulation in the brain and neurodegenerative disorders |
| 04/07/1999 | EP0770059B1 Substituted benzamidines, their production and their use as medicaments |